Ultherapy PRIME vs Legacy Ultherapy: What's the Actual Difference?
Summary:
|
You finally decided to look into Ultherapy. Then you noticed some clinics advertising Ultherapy PRIME instead, and are left wondering what the difference or significance is in mentioning PRIME.
It is a reasonable thing to wonder. In 2024, Merz Aesthetics released the second-generation version of the platform, Ultherapy PRIME. The core technology behind both is the same: microfocused ultrasound targeting the superficial musculo-aponeurotic system (SMAS) layer with real-time imaging guidance.
This Ultherapy PRIME vs Legacy Ultherapy breakdown covers exactly what is different, what stayed the same, and what it means for anyone booking a treatment today.
What Is Legacy Ultherapy, and Why Does It Still Matter?
Ultherapy, now referred to as Legacy Ultherapy, was first cleared by the US Food and Drug Administration (FDA) in 2009 for non-invasive brow lifting. That clearance was subsequently extended to the under-chin, neck, and décolletage.
The technology is microfocused ultrasound with visualisation (MFU-V): focused acoustic energy delivered to the superficial musculo-aponeurotic system (SMAS) at 4.5mm depth, the mid-dermis at 3.0mm, and the superficial dermis at 1.5mm, with real-time imaging allowing the treating doctor to view tissue layers before energy is delivered.
According to Merz Aesthetics, over three million treatments have been performed globally, supported by more than 120 peer-reviewed publications. Ultherapy PRIME is built on this foundation.
What Is Ultherapy PRIME?
Ultherapy PRIME is the second-generation MFU-V platform from Merz Aesthetics, introduced to Singapore at the end of 2024. It uses the same foundational technology with updates to the imaging system, treatment speed, and handpiece design.
Cambridge Medical (Somerset) is a certified Ultherapy PRIME clinic; patients booking today will be treated on the PRIME platform.
How Ultherapy PRIME Differs from Legacy Ultherapy
The following changes were introduced with the PRIME platform. Each is a device-level change rather than a change to the underlying technology.
Imaging screen: 35% larger. According to the official Merz Aesthetics launch announcement, the PRIME platform features a 35% larger screen for real-time visualisation, allowing the treating doctor to view tissue layers during the See Plan Treat protocol
Sharper imaging. The imaging resolution has been upgraded, which is particularly relevant in areas where anatomy varies significantly between patients, such as around the jaw, cheekbones, and brow.
Updated handpiece. The PRIME handpiece has been updated for improved ergonomics, with updated ergonomics for hand positioning during delivery.
What has not changed:
The foundational technology: microfocused ultrasound with real-time visualisation.
Tissue depths: 4.5mm (SMAS), 3.0mm (mid-dermis), and 1.5mm (superficial dermis).
The collagen response mechanism. Results still develop over two to six months.
US FDA clearance for brow lifting, under-chin, neck, and décolletage carries forward.
The clinical evidence base, over 120 peer-reviewed publications and more than 50 clinical studies according to Merz Aesthetics, supports the same MFU-V technology.
Legacy Ultherapy vs Ultherapy PRIME: A Side-by-Side Comparison
Feature | Legacy Ultherapy | Ultherapy PRIME |
Screen size | Standard | 35% larger |
Treatment speed | Standard | Up to 20% faster (provider-reported) |
Imaging quality | Standard | High Resolution |
Ergonomics | Standard handpiece | Updated handpiece |
Core technology | MFU-V | MFU-V (unchanged) |
FDA clearance | Brow, under-chin, neck, décolletage | Same, carried forward |
Tissue depths | 4.5mm / 3.0mm / 1.5mm | Same |
Result timeline | Two to six months | Same |
Availability in Singapore | Succeeded by PRIME | Current platform at Cambridge Medical (Somerset) |
Do the Clinical Results Differ Between the Two Platforms?
The core collagen-stimulating mechanism is the same between the two platforms. The biological response, fibroblast activation and new collagen production, is identical. The primary differences of Ultherapy PRIME are in the treatment experience: delivery, imaging, and ergonomics.
A 2025 peer-reviewed pilot study of 30 patients in Singapore found most participants achieved clinically meaningful improvement in jawline and neck laxity following a single Ultherapy PRIME treatment, with all physicians and patients reporting aesthetic improvement. Long-term comparative studies between the two generations are still developing.
The PRIME platform delivers the same MFU-V technology supported by an established clinical record, with updated delivery mechanics.
Ultherapy PRIME vs HIFU: What Is the Difference?
Both Ultherapy PRIME and HIFU use focused ultrasound energy. Unlike laser treatments or radiofrequency treatments, both deliver focused ultrasound beneath the skin. The distinctions lie in how that energy is guided, regulated, and standardised.
Ultherapy PRIME | HIFU (as a category) | |
|---|---|---|
Real-time visualisation | Included as standard via the See Plan Treat protocol, allowing the treating doctor to view tissue layers before energy is delivered | Varies by device. Some HIFU systems include imaging; others use preset depth settings. Patients should confirm with their clinic which system is being used |
Regulatory clearance | Holds specific US FDA clearance for brow lifting, under-chin, neck, and décolletage | Regulatory status varies by country and device. Many HIFU devices hold clearances in their respective markets, including HSA clearance in Singapore |
Device standardisation | A single device from one manufacturer (Merz Aesthetics), with a Certificate of Authenticity programme | A broad category covering multiple devices from different manufacturers. Energy parameters, transducer depths, and protocols differ between systems |
HIFU as a category encompasses a wide range of devices, which means outcomes, protocols, and the presence or absence of imaging guidance can differ considerably between clinics and machines. Ultherapy PRIME is one specific, standardised device within the broader focused ultrasound family.
Neither is categorically superior. The right choice depends on the patient's goals, the specific device available at a clinic, and the treating doctor's assessment.
What to Expect at Cambridge Medical (Somerset)
With over twelve years of experience in aesthetic medicine, Dr Shirley Kwee performs Ultherapy PRIME using the authentic Merz Aesthetics device at Cambridge Medical (Somerset).
Every treatment begins with the See Plan Treat protocol, with depth, density, and treatment vectors adjusted to each patient's individual anatomy. The first step is a consultation to assess your skin concerns and confirm whether Ultherapy PRIME is the appropriate treatment for your goals.
Frequently Asked Questions
These are the questions patients most commonly raise about the upgrade and how the two platforms compare.
Is Ultherapy PRIME available at Cambridge Medical (Somerset)?
Yes. Cambridge Medical (Somerset) is a certified Ultherapy PRIME clinic. All patients treated today will receive the PRIME platform.
Is Ultherapy PRIME the same as HIFU?
How long does Ultherapy PRIME take compared to the legacy?
Do I need to redo my treatment now that the device has been upgraded?
How long do Ultherapy PRIME results last?
Ready to Discuss Whether Ultherapy PRIME Is Right for You?
Whether you are a first-time patient or someone who has had previous Ultherapy treatments, if you have questions about Ultherapy PRIME, a consultation is the right place to start.
With over ten years of experience in aesthetic medicine, Dr Shirley Kwee at Cambridge Medical (Somerset) will assess your skin concerns and confirm whether Ultherapy PRIME is appropriate for your goals.
Book a consultation at Cambridge Medical (Somerset).
Written by: Dr Shirley Kwee, Cambridge Medical Group (Somerset), 321 Orchard Road, Singapore.
Related reading: Ultherapy PRIME at Cambridge Medical (Somerset) | What Is Ultherapy? A Guide to Ultrasound-Based Skin Lifting